NR2F6 | nuclear receptor subfamily 2, group F, member 6 | 19p13.11 | 0.544 | 0.753 | 0
|
SH3GLB2 | SH3-domain GRB2-like endophilin B2 | 9q34 | 0.501 | 0.715 | 0
|
BCAT2 | branched chain amino-acid transaminase 2, mitochondrial | 19q13.33 | 0.455 | 0.65 | 0
|
VSIG2 | V-set and immunoglobulin domain containing 2 | 11q24 | 0.447 | 0.663 | 0
|
ADIRF | adipogenesis regulatory factor | 10q23.31 | 0.447 | 0.698 | 0
|
SNCG | synuclein, gamma (breast cancer-specific protein 1) | 10q23.2-q23.3 | 0.442 | 0.647 | 0
|
GIPC1 | GIPC PDZ domain containing family, member 1 | 19p13.1 | 0.427 | 0.575 | 0
|
KLHL5 | kelch-like family member 5 | 4p15.1 | 0.421 | -0.604 | 0
|
SSH3 | slingshot protein phosphatase 3 | 11q13 | 0.419 | 0.605 | 0
|
UPK2 | uroplakin 2 | 11q23 | 0.418 | 0.659 | 0
|
S100P | S100 calcium binding protein P | 4p16 | 0.417 | 0.668 | 0
|
GNB4 | guanine nucleotide binding protein (G protein), beta polypeptide 4 | 3q27.1 | 0.417 | -0.575 | 0
|
TRAF4 | TNF receptor-associated factor 4 | 17q11-q21.3 | 0.416 | 0.6 | 0
|
RAB25 | RAB25, member RAS oncogene family | 1q22 | 0.414 | 0.561 | 0
|
ARRDC1 | arrestin domain containing 1 | 9q34.3 | 0.413 | 0.6 | 0
|
EPN3 | epsin 3 | 17q21.33 | 0.412 | 0.632 | 0
|
PSCA | prostate stem cell antigen | 8q24.2 | 0.411 | 0.589 | 0
|
EVPL | envoplakin | 17q25.1 | 0.411 | 0.613 | 0
|
B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | 19p13.1 | 0.41 | 0.605 | 0
|
ACSF2 | acyl-CoA synthetase family member 2 | 17q21.33 | 0.405 | 0.61 | 0
|
KATNAL1 | katanin p60 subunit A-like 1 | 13q12.3 | 0.402 | -0.62 | 0
|
THEM6 | thioesterase superfamily member 6 | 8q24.3 | 0.402 | 0.609 | 0
|
CEP170 | centrosomal protein 170kDa | 1q44 | 0.4 | -0.538 | 0
|
HID1 | HID1 domain containing | 17q25.1 | 0.4 | 0.647 | 0
|
S100A6 | S100 calcium binding protein A6 | 1q21 | 0.399 | 0.621 | 0
|
LOC653653 | | | 0.398 | -0.551 | 0
|
RABEP2 | rabaptin, RAB GTPase binding effector protein 2 | 16p11.2 | 0.396 | 0.559 | 0
|
SLC44A3 | solute carrier family 44, member 3 | 1p22.1 | 0.396 | 0.594 | 0
|
SLC29A3 | solute carrier family 29 (equilibrative nucleoside transporter), member 3 | 10q22.2 | 0.395 | 0.668 | 0
|
BMP2K | BMP2 inducible kinase | 4q21.21 | 0.395 | -0.59 | 0
|
RAB11FIP4 | RAB11 family interacting protein 4 (class II) | 17q11.2 | 0.395 | 0.581 | 0
|
TMEM184A | transmembrane protein 184A | 7p22.3 | 0.394 | 0.575 | 0
|
ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 2q31-q32 | 0.393 | -0.441 | 0
|
MMP15 | matrix metallopeptidase 15 (membrane-inserted) | 16q13 | 0.392 | 0.626 | 0
|
ERBB2 | erb-b2 receptor tyrosine kinase 2 | 17q11.2-q12 | 0.391 | 0.604 | 0
|
SIRT7 | sirtuin 7 | 17q25.3 | 0.39 | 0.553 | 0
|
ZNF823 | zinc finger protein 823 | 19p13.2 | 0.389 | 0.531 | 0
|
SACS | sacsin molecular chaperone | 13q11 | 0.388 | -0.585 | 0
|
BCAS1 | breast carcinoma amplified sequence 1 | 20q13.2 | 0.387 | 0.59 | 0
|
CLDN4 | claudin 4 | 7q11.23 | 0.386 | 0.562 | 0
|
PLEKHG6 | pleckstrin homology domain containing, family G (with RhoGef domain) member 6 | 12p13.31 | 0.386 | 0.601 | 0
|
RECQL | RecQ helicase-like | 12p12.1 | 0.385 | -0.579 | 0
|
PLA2G2F | phospholipase A2, group IIF | 1p35 | 0.385 | 0.614 | 0
|
CAPN5 | calpain 5 | 11q14 | 0.385 | 0.582 | 0
|
ECHS1 | enoyl CoA hydratase, short chain, 1, mitochondrial | 10q26.2-q26.3 | 0.384 | 0.625 | 0
|
TM7SF2 | transmembrane 7 superfamily member 2 | 11q13.1 | 0.383 | 0.55 | 0
|
ANKRD13D | ankyrin repeat domain 13 family, member D | 11q13.2 | 0.383 | 0.534 | 0
|
SPINK1 | serine peptidase inhibitor, Kazal type 1 | 5q32 | 0.383 | 0.564 | 0
|
CPTP | ceramide-1-phosphate transfer protein | 1p36.33 | 0.382 | 0.558 | 0
|
VGLL1 | vestigial-like family member 1 | Xq26.3 | 0.381 | 0.607 | 0
|
OSBPL6 | oxysterol binding protein-like 6 | 2q32.1 | 0.381 | -0.566 | 0
|
ACAA1 | acetyl-CoA acyltransferase 1 | 3p22.2 | 0.381 | 0.615 | 0
|
DENND2D | DENN/MADD domain containing 2D | 1p13.3 | 0.38 | 0.531 | 0
|
TRAK1 | trafficking protein, kinesin binding 1 | 3p22.1 | 0.38 | 0.569 | 0
|
MSN | moesin | Xq11.1 | 0.379 | -0.566 | 0
|
RAB27A | RAB27A, member RAS oncogene family | 15q21.3 | 0.378 | -0.563 | 0
|
MPHOSPH9 | M-phase phosphoprotein 9 | 12q24 | 0.378 | -0.532 | 0
|
PHLDB3 | pleckstrin homology-like domain, family B, member 3 | 19q13.31 | 0.377 | 0.624 | 0
|
KRT7 | keratin 7, type II | 12q13.13 | 0.377 | 0.575 | 0
|
SGCB | sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) | 4q12 | 0.377 | -0.583 | 0
|
TMPRSS2 | transmembrane protease, serine 2 | 21q22.3 | 0.377 | 0.561 | 0
|
SEC23A | Sec23 homolog A, COPII coat complex component | 14q21.1 | 0.376 | -0.503 | 0
|
ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 17q12 | 0.376 | 0.593 | 0
|
OGFRL1 | opioid growth factor receptor-like 1 | 6q13 | 0.376 | -0.58 | 0
|
FAM174B | family with sequence similarity 174, member B | 15q26.1 | 0.375 | 0.59 | 0
|
ZNF524 | zinc finger protein 524 | 19q13.43 | 0.374 | 0.499 | 0
|
LLGL2 | lethal giant larvae homolog 2 (Drosophila) | 17q25.1 | 0.372 | 0.592 | 0
|
BTBD16 | BTB (POZ) domain containing 16 | 10q26.13 | 0.372 | 0.575 | 0
|
ACOX1 | acyl-CoA oxidase 1, palmitoyl | 17q25.1 | 0.372 | 0.544 | 0
|
FAM126A | family with sequence similarity 126, member A | 7p15.3 | 0.371 | -0.58 | 0
|
TNNC1 | troponin C type 1 (slow) | 3p21.1 | 0.371 | 0.609 | 0
|
PCBD1 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha | 10q22 | 0.369 | 0.596 | 0
|
SAV1 | salvador family WW domain containing protein 1 | 14q13-q23 | 0.369 | -0.594 | 0
|
TMEM134 | transmembrane protein 134 | 11q13.2 | 0.369 | 0.555 | 0
|
HIP1R | huntingtin interacting protein 1 related | 12q24 | 0.369 | 0.577 | 0
|
ABHD12 | abhydrolase domain containing 12 | 20p11.21 | 0.369 | 0.632 | 0
|
ASCC2 | activating signal cointegrator 1 complex subunit 2 | 22q12.1 | 0.368 | 0.603 | 0
|
UPK3A | uroplakin 3A | 22q13.31 | 0.368 | 0.571 | 0
|
SPATA2L | spermatogenesis associated 2-like | 16q24.3 | 0.368 | 0.529 | 0
|
GDPD3 | glycerophosphodiester phosphodiesterase domain containing 3 | 16p11.2 | 0.368 | 0.575 | 0
|
RAB15 | RAB15, member RAS oncogene family | 14q23.2 | 0.368 | 0.63 | 0
|
KIAA0922 | KIAA0922 | 4q31.3 | 0.367 | -0.594 | 0
|
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | 20q12-q13 | 0.366 | 0.529 | 0
|
COMT | catechol-O-methyltransferase | 22q11.21 | 0.366 | 0.611 | 0
|
CCDC88A | coiled-coil domain containing 88A | 2p16.3 | 0.366 | -0.606 | 0
|
MFHAS1 | malignant fibrous histiocytoma amplified sequence 1 | 8p23.1 | 0.366 | -0.513 | 0
|
SYTL1 | synaptotagmin-like 1 | 1p35.3 | 0.365 | 0.522 | 0
|
NT5C2 | 5'-nucleotidase, cytosolic II | 10q24.32 | 0.364 | 0.615 | 0
|
PRRG2 | proline rich Gla (G-carboxyglutamic acid) 2 | 19q13.33 | 0.362 | 0.478 | 0
|
TMC4 | transmembrane channel-like 4 | 19q13.42 | 0.362 | 0.535 | 0
|
CNGA1 | cyclic nucleotide gated channel alpha 1 | 4p12 | 0.361 | 0.549 | 0
|
SMIM6 | small integral membrane protein 6 | 17q25.1 | 0.36 | 0.581 | 0
|
C17orf82 | chromosome 17 open reading frame 82 | 17q23.2 | 0.359 | 0.546 | 0
|
EGFL8 | EGF-like-domain, multiple 8 | 6p21 | 0.359 | 0.485 | 0
|
PP14571 | | | 0.358 | 0.598 | 0
|
ACOXL | acyl-CoA oxidase-like | 2q13 | 0.357 | 0.513 | 0
|
PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 17q25.3 | 0.357 | 0.561 | 0
|
SAMHD1 | SAM domain and HD domain 1 | 20q11.23 | 0.357 | -0.544 | 0
|
TMEM63A | transmembrane protein 63A | 1q42.12 | 0.357 | 0.593 | 0
|
SPSB3 | splA/ryanodine receptor domain and SOCS box containing 3 | 16p13.3 | 0.356 | 0.538 | 0
|
KRT8 | keratin 8, type II | 12q13.13 | 0.355 | 0.605 | 0
|
UPK3B | uroplakin 3B | 7q11.2 | 0.355 | 0.558 | 0
|
SGSM3 | small G protein signaling modulator 3 | 22q13.1-q13.2 | 0.354 | 0.603 | 0
|
CCDC12 | coiled-coil domain containing 12 | 3p21.31 | 0.354 | 0.543 | 0
|
TEN1 | TEN1 CST complex subunit | 17q25.1 | 0.353 | 0.501 | 0
|
NADSYN1 | NAD synthetase 1 | 11q13.4 | 0.353 | 0.578 | 0
|
NCK1 | NCK adaptor protein 1 | 3q21 | 0.353 | -0.55 | 0
|
MSX2 | msh homeobox 2 | 5q35.2 | 0.352 | 0.563 | 0
|
PERM1 | PPARGC1 and ESRR induced regulator, muscle 1 | 1p36.33 | 0.352 | 0.552 | 0
|
AK4 | adenylate kinase 4 | 1p31.3 | 0.351 | -0.562 | 0
|
NXPE3 | neurexophilin and PC-esterase domain family, member 3 | 3q12.3 | 0.351 | -0.556 | 0
|
KRT19 | keratin 19, type I | 17q21.2 | 0.351 | 0.496 | 0
|
PICK1 | protein interacting with PRKCA 1 | 22q13.1 | 0.351 | 0.52 | 0
|
TMC6 | transmembrane channel-like 6 | 17q25.3 | 0.351 | 0.527 | 0
|
ME1 | malic enzyme 1, NADP(+)-dependent, cytosolic | 6q12 | 0.35 | -0.494 | 0
|
TMEM53 | transmembrane protein 53 | 1p34.1 | 0.35 | 0.548 | 0
|
SLC30A2 | solute carrier family 30 (zinc transporter), member 2 | 1p35.3 | 0.349 | 0.526 | 0
|
RASSF7 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 | 11p15.5 | 0.348 | 0.537 | 0
|
DNAL4 | dynein, axonemal, light chain 4 | 22q13.1 | 0.348 | 0.553 | 0
|
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 1q32.2 | 0.347 | 0.539 | 0
|
DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 19q13.2 | 0.347 | 0.461 | 0
|
RPS19BP1 | ribosomal protein S19 binding protein 1 | 22q13.1 | 0.347 | 0.543 | 0
|
CACFD1 | calcium channel flower domain containing 1 | 9q34 | 0.347 | 0.541 | 0
|
SHOX2 | short stature homeobox 2 | 3q25.32 | 0.347 | -0.489 | 0
|
UBALD2 | UBA-like domain containing 2 | 17q25.1 | 0.347 | 0.49 | 0
|
CAMK2G | calcium/calmodulin-dependent protein kinase II gamma | 10q22 | 0.346 | 0.438 | 0
|
TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | 6p21.1 | 0.346 | 0.473 | 0
|
TMEM54 | transmembrane protein 54 | 1p35-p34 | 0.345 | 0.517 | 0
|
SMIM5 | small integral membrane protein 5 | 17q25.1 | 0.345 | 0.561 | 0
|
CLDN23 | claudin 23 | 8p23.1 | 0.345 | 0.55 | 0
|
MPST | mercaptopyruvate sulfurtransferase | 22q13.1 | 0.345 | 0.57 | 0
|
BICD1 | bicaudal D homolog 1 (Drosophila) | 12p11.2-p11.1 | 0.344 | -0.575 | 0
|
SPINT1 | serine peptidase inhibitor, Kunitz type 1 | 15q13.3 | 0.344 | 0.562 | 0
|
CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 19q13.1 | 0.344 | 0.547 | 0
|
RAB40C | RAB40C, member RAS oncogene family | 16p13.3 | 0.342 | 0.551 | 0
|
ABHD11 | abhydrolase domain containing 11 | 7q11.23 | 0.342 | 0.508 | 0
|
PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase, type II, alpha | 10p12.2 | 0.342 | -0.462 | 0
|
FER | fer (fps/fes related) tyrosine kinase | 5q21 | 0.342 | -0.505 | 0
|
FXYD4 | FXYD domain containing ion transport regulator 4 | 10q11.21 | 0.341 | 0.608 | 0
|
SERINC2 | serine incorporator 2 | 1p35.1 | 0.341 | 0.462 | 0
|
ELOVL1 | ELOVL fatty acid elongase 1 | 1p34 | 0.341 | 0.579 | 0
|
HS3ST6 | heparan sulfate (glucosamine) 3-O-sulfotransferase 6 | 16p13.3 | 0.341 | 0.526 | 0
|
TNK2 | tyrosine kinase, non-receptor, 2 | 3q29 | 0.341 | 0.539 | 0
|
PEX14 | peroxisomal biogenesis factor 14 | 1p36.22 | 0.34 | 0.373 | 1.39e-15
|
SLC25A46 | solute carrier family 25, member 46 | 5q22.1 | 0.339 | -0.478 | 0
|
AGAP3 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 | 7q36.1 | 0.339 | 0.503 | 0
|
NPRL2 | NPR2-like, GATOR1 complex subunit | 3p21.3 | 0.338 | 0.523 | 0
|
EHBP1 | EH domain binding protein 1 | 2p15 | 0.338 | -0.539 | 0
|
TSPAN14 | tetraspanin 14 | 10q23.1 | 0.338 | 0.54 | 0
|
FSD1L | fibronectin type III and SPRY domain containing 1-like | 9q31 | 0.338 | -0.534 | 0
|
MED25 | mediator complex subunit 25 | 19q13.3 | 0.338 | 0.505 | 0
|
GPATCH11 | G patch domain containing 11 | 2p22.2 | 0.338 | -0.463 | 0
|
YPEL3 | yippee-like 3 | 16p11.2 | 0.338 | 0.552 | 0
|
ST3GAL4 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 | 11q23-q24 | 0.338 | 0.599 | 0
|
GLTSCR2 | glioma tumor suppressor candidate region gene 2 | 19q13.3 | 0.338 | 0.425 | 0
|
LMBR1L | limb development membrane protein 1-like | 12q13.12 | 0.337 | 0.514 | 0
|
INPP5A | inositol polyphosphate-5-phosphatase A | 10q26.3 | 0.337 | 0.524 | 0
|
UQCR10 | ubiquinol-cytochrome c reductase, complex III subunit X | 22q12.2 | 0.337 | 0.563 | 0
|
GRB7 | growth factor receptor-bound protein 7 | 17q12 | 0.336 | 0.52 | 0
|
RIF1 | replication timing regulatory factor 1 | 2q23.3 | 0.336 | -0.492 | 0
|
MB21D1 | Mab-21 domain containing 1 | 6q13 | 0.336 | -0.531 | 0
|
HRH2 | histamine receptor H2 | 5q35 | 0.336 | -0.39 | 0
|
OXCT1 | 3-oxoacid CoA transferase 1 | 5p13 | 0.336 | -0.57 | 0
|
GPX8 | glutathione peroxidase 8 (putative) | 5q11.2 | 0.336 | -0.47 | 0
|
ARL13B | ADP-ribosylation factor-like 13B | 3q11 | 0.335 | -0.564 | 0
|
HPS5 | Hermansky-Pudlak syndrome 5 | 11p14 | 0.335 | -0.506 | 0
|
HELB | helicase (DNA) B | 12q14.2 | 0.335 | -0.533 | 0
|
SLC44A2 | solute carrier family 44 (choline transporter), member 2 | 19p13.2 | 0.334 | 0.565 | 0
|
TST | thiosulfate sulfurtransferase (rhodanese) | 22q13.1 | 0.334 | 0.593 | 0
|
C10orf95 | chromosome 10 open reading frame 95 | 10q24.32 | 0.334 | 0.509 | 0
|
NUP155 | nucleoporin 155kDa | 5p13.1 | 0.332 | -0.438 | 0
|
PAM | peptidylglycine alpha-amidating monooxygenase | 5q | 0.332 | -0.501 | 0
|
C19orf33 | chromosome 19 open reading frame 33 | 19q13.2 | 0.332 | 0.458 | 0
|
CDH23 | cadherin-related 23 | 10q22.1 | 0.332 | 0.485 | 0
|
MFSD5 | major facilitator superfamily domain containing 5 | 12q13.13 | 0.331 | 0.586 | 0
|
SH2D3A | SH2 domain containing 3A | 19p13.3 | 0.331 | 0.456 | 0
|
GDF15 | growth differentiation factor 15 | 19p13.11 | 0.33 | 0.52 | 0
|
RAP1GAP | RAP1 GTPase activating protein | 1p36.1-p35 | 0.33 | 0.549 | 0
|
OSBPL8 | oxysterol binding protein-like 8 | 12q14 | 0.33 | -0.518 | 0
|
PRKCZ | protein kinase C, zeta | 1p36.33-p36.2 | 0.33 | 0.536 | 0
|
DSE | dermatan sulfate epimerase | 6q22 | 0.329 | -0.442 | 0
|
KIAA1522 | KIAA1522 | 1p35.1 | 0.329 | 0.503 | 0
|
ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | 4q21 | 0.329 | -0.417 | 0
|
KRT18 | keratin 18, type I | 12q13 | 0.329 | 0.577 | 0
|
LRP12 | low density lipoprotein receptor-related protein 12 | 8q22.2 | 0.329 | -0.457 | 0
|
FAM134C | family with sequence similarity 134, member C | 17q21.2 | 0.328 | 0.459 | 0
|
PLEKHJ1 | pleckstrin homology domain containing, family J member 1 | 19p13.3 | 0.328 | 0.451 | 0
|
STARD10 | StAR-related lipid transfer (START) domain containing 10 | 11q13 | 0.328 | 0.492 | 0
|
SCAND1 | SCAN domain containing 1 | 20q11.1-q11.23 | 0.328 | 0.471 | 0
|
PUSL1 | pseudouridylate synthase-like 1 | 1p36.33 | 0.328 | 0.56 | 0
|
VPS28 | vacuolar protein sorting 28 homolog (S. cerevisiae) | 8q24.3 | 0.328 | 0.483 | 0
|
LIN52 | lin-52 DREAM MuvB core complex component | 14q24.2 | 0.326 | -0.514 | 0
|
KCNN4 | potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 | 19q13.2 | 0.326 | 0.519 | 0
|
TTC39A | tetratricopeptide repeat domain 39A | 1p32.3 | 0.325 | 0.419 | 0
|
TPRN | taperin | 9q34.3 | 0.325 | 0.563 | 0
|
SPINT2 | serine peptidase inhibitor, Kunitz type, 2 | 19q13.2 | 0.325 | 0.404 | 0
|
CORO1B | coronin, actin binding protein, 1B | 11q13.1 | 0.325 | 0.541 | 0
|
LYPLA2 | lysophospholipase II | 1p36.11 | 0.325 | 0.486 | 0
|
TRPM4 | transient receptor potential cation channel, subfamily M, member 4 | 19q13.3 | 0.324 | 0.521 | 0
|
PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 6q12 | 0.324 | -0.495 | 0
|
CBY1 | chibby homolog 1 (Drosophila) | 22q12 | 0.324 | 0.452 | 0
|
QKI | QKI, KH domain containing, RNA binding | 6q26 | 0.324 | -0.429 | 0
|
DENND5A | DENN/MADD domain containing 5A | 11p15.3 | 0.323 | -0.483 | 0
|
EPS8L1 | EPS8-like 1 | 19q13.42 | 0.323 | 0.513 | 0
|
GET4 | golgi to ER traffic protein 4 | 7p22.3 | 0.322 | 0.504 | 0
|
KIAA1524 | KIAA1524 | 3q13.13 | 0.322 | -0.473 | 0
|
TMEM191A | transmembrane protein 191A (pseudogene) | 22q11.21 | 0.321 | 0.505 | 0
|
ARHGAP8 | Rho GTPase activating protein 8 | 22q13.3 | 0.321 | 0.492 | 0
|
ZNF341 | zinc finger protein 341 | 20q11.22 | 0.321 | 0.512 | 0
|
SLC23A3 | solute carrier family 23, member 3 | 2q35 | 0.321 | 0.481 | 0
|
ACOT11 | acyl-CoA thioesterase 11 | 1p32.3 | 0.321 | 0.465 | 0
|
PPP2R2D | protein phosphatase 2, regulatory subunit B, delta | 10q26.3 | 0.321 | 0.584 | 0
|
PCNXL4 | pecanex-like 4 (Drosophila) | 14q23.1 | 0.32 | -0.502 | 0
|
TUSC2 | tumor suppressor candidate 2 | 3p21.3 | 0.318 | 0.532 | 0
|
PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 3q24 | 0.318 | -0.502 | 0
|
RER1 | retention in endoplasmic reticulum sorting receptor 1 | 1p36 | 0.318 | 0.518 | 0
|
CHMP4B | charged multivesicular body protein 4B | 20q11.22 | 0.317 | 0.444 | 0
|
USP13 | ubiquitin specific peptidase 13 (isopeptidase T-3) | 3q26.2-q26.3 | 0.317 | -0.557 | 0
|
TSPAN15 | tetraspanin 15 | 10q22.1 | 0.317 | 0.529 | 0
|
FGD3 | FYVE, RhoGEF and PH domain containing 3 | 9q22 | 0.317 | 0.533 | 0
|
C1orf116 | chromosome 1 open reading frame 116 | 1q32.1 | 0.316 | 0.506 | 0
|
TEAD3 | TEA domain family member 3 | 6p21.2 | 0.316 | 0.439 | 0
|
TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 1p34.3 | 0.316 | 0.445 | 0
|
VAMP8 | vesicle-associated membrane protein 8 | 2p12-p11.2 | 0.316 | 0.489 | 0
|
MBNL1 | muscleblind-like splicing regulator 1 | 3q25 | 0.316 | -0.537 | 0
|
POLL | polymerase (DNA directed), lambda | 10q23 | 0.316 | 0.477 | 0
|
ILVBL | ilvB (bacterial acetolactate synthase)-like | 19p13.1 | 0.315 | 0.543 | 0
|
UNC93B1 | unc-93 homolog B1 (C. elegans) | 11q13.2 | 0.315 | 0.497 | 0
|
WNT7B | wingless-type MMTV integration site family, member 7B | 22q13 | 0.315 | 0.469 | 0
|
ANKRD65 | ankyrin repeat domain 65 | 1p36.33 | 0.315 | 0.526 | 0
|
CLN3 | ceroid-lipofuscinosis, neuronal 3 | 16p12 | 0.314 | 0.526 | 0
|
SOX13 | SRY (sex determining region Y)-box 13 | 1q32 | 0.314 | 0.451 | 0
|
SP3 | Sp3 transcription factor | 2q31 | 0.314 | -0.434 | 0
|
KISS1 | KiSS-1 metastasis-suppressor | 1q32 | 0.313 | 0.495 | 0
|
DOCK10 | dedicator of cytokinesis 10 | 2q36.3 | 0.313 | -0.435 | 0
|
FAM118A | family with sequence similarity 118, member A | 22q13.3 | 0.313 | 0.541 | 0
|
GPR161 | G protein-coupled receptor 161 | 1q23.3 | 0.312 | -0.493 | 0
|
BATF | basic leucine zipper transcription factor, ATF-like | 14q24 | 0.312 | 0.524 | 0
|
SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 5q32 | 0.312 | 0.516 | 0
|
BAIAP3 | BAI1-associated protein 3 | 16p13.3 | 0.311 | 0.527 | 0
|
SYNGR2 | synaptogyrin 2 | 17q25.3 | 0.311 | 0.437 | 0
|
RNGTT | RNA guanylyltransferase and 5'-phosphatase | 6q16 | 0.311 | -0.472 | 0
|
TMEM8A | transmembrane protein 8A | 16p13.3 | 0.31 | 0.508 | 0
|
RAB17 | RAB17, member RAS oncogene family | 2q37.3 | 0.31 | 0.44 | 0
|
MGAT1 | mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase | 5q35.3 | 0.31 | 0.523 | 0
|
EPS8L2 | EPS8-like 2 | 11p15.5 | 0.31 | 0.44 | 0
|
LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 11q13.4 | 0.31 | 0.46 | 0
|
TMEM222 | transmembrane protein 222 | 1p36.11 | 0.31 | 0.356 | 4.69e-14
|
SYT8 | synaptotagmin VIII | 11p15.5 | 0.309 | 0.448 | 0
|
PCDH1 | protocadherin 1 | 5q31.3 | 0.309 | 0.541 | 0
|
ATXN1 | ataxin 1 | 6p23 | 0.308 | -0.456 | 0
|
WDHD1 | WD repeat and HMG-box DNA binding protein 1 | 14q22.2 | 0.307 | -0.437 | 0
|
NBEAL2 | neurobeachin-like 2 | 3p21.31 | 0.307 | 0.464 | 0
|
C11orf31 | chromosome 11 open reading frame 31 | 11q12.1 | 0.307 | 0.429 | 0
|
MRPL43 | mitochondrial ribosomal protein L43 | 10q24.31 | 0.307 | 0.488 | 0
|
KLF12 | Kruppel-like factor 12 | 13q22 | 0.306 | -0.47 | 0
|
PLEKHN1 | pleckstrin homology domain containing, family N member 1 | 1p36.33 | 0.306 | 0.475 | 0
|
CHSY1 | chondroitin sulfate synthase 1 | 15q26.3 | 0.306 | -0.451 | 0
|
ZNF768 | zinc finger protein 768 | 16p11.2 | 0.305 | 0.429 | 0
|
DUBR | DPPA2 upstream binding RNA | 3q13.12 | 0.305 | -0.503 | 0
|
UCA1 | urothelial cancer associated 1 (non-protein coding) | 19p13.12 | 0.305 | 0.477 | 0
|
NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | 14q22.2 | 0.304 | -0.448 | 0
|
NCR3LG1 | natural killer cell cytotoxicity receptor 3 ligand 1 | 11p15.1 | 0.304 | -0.457 | 0
|
MACROD1 | MACRO domain containing 1 | 11q13.1 | 0.304 | 0.452 | 0
|
TMEM105 | transmembrane protein 105 | 17q25.3 | 0.304 | 0.495 | 0
|
NEDD1 | neural precursor cell expressed, developmentally down-regulated 1 | 12q23.1 | 0.304 | -0.489 | 0
|
MYLPF | myosin light chain, phosphorylatable, fast skeletal muscle | 16p11.2 | 0.304 | 0.455 | 0
|
SYNGR1 | synaptogyrin 1 | 22q13 | 0.303 | 0.455 | 0
|
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | 19q13.2 | 0.303 | 0.521 | 0
|
HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 1p36.1-p35 | 0.302 | 0.474 | 0
|
TAF4B | TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa | 18q11.1 | 0.302 | -0.51 | 0
|
CD47 | CD47 molecule | 3q13.1-q13.2 | 0.301 | -0.426 | 0
|
GBE1 | glucan (1,4-alpha-), branching enzyme 1 | 3p12.2 | 0.301 | -0.472 | 0
|
PAQR7 | progestin and adipoQ receptor family member VII | 1p35.3 | 0.3 | 0.545 | 0
|
TRMT44 | tRNA methyltransferase 44 homolog (S. cerevisiae) | 4p16.1 | 0.3 | 0.424 | 0
|
IMP3 | IMP3, U3 small nucleolar ribonucleoprotein | 15q24 | 0.3 | 0.428 | 0
|
POPDC3 | popeye domain containing 3 | 6q21 | 0.3 | -0.421 | 0
|
FUT3 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | 19p13.3 | 0.3 | 0.374 | 1.31e-15
|
CNOT11 | CCR4-NOT transcription complex, subunit 11 | 2q12.1 | 0.299 | 0.424 | 0
|
PTPRU | protein tyrosine phosphatase, receptor type, U | 1p35.3 | 0.299 | 0.46 | 0
|
RNF138 | ring finger protein 138, E3 ubiquitin protein ligase | 18q12.1 | 0.298 | -0.474 | 0
|
QARS | glutaminyl-tRNA synthetase | 3p21.31 | 0.298 | 0.499 | 0
|
PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) | 12p12.1 | 0.297 | -0.43 | 0
|
GFOD2 | glucose-fructose oxidoreductase domain containing 2 | 16q22.1 | 0.297 | 0.451 | 0
|
ST14 | suppression of tumorigenicity 14 (colon carcinoma) | 11q24-q25 | 0.296 | 0.367 | 5.13e-15
|
TTC26 | tetratricopeptide repeat domain 26 | 7q34 | 0.295 | -0.464 | 0
|
BCAP31 | B-cell receptor-associated protein 31 | Xq28 | 0.295 | 0.428 | 0
|
AIM1L | absent in melanoma 1-like | 1p35 | 0.295 | 0.466 | 0
|
CDC42EP5 | CDC42 effector protein (Rho GTPase binding) 5 | 19q13.42 | 0.294 | 0.426 | 0
|
LPCAT4 | lysophosphatidylcholine acyltransferase 4 | 15q14 | 0.293 | 0.449 | 0
|
RAPGEF5 | Rap guanine nucleotide exchange factor (GEF) 5 | 7p15.3 | 0.293 | -0.452 | 0
|
SLC38A10 | solute carrier family 38, member 10 | 17q25.3 | 0.293 | 0.476 | 0
|
TMEM237 | transmembrane protein 237 | 2q33 | 0.293 | -0.476 | 0
|
SLC16A5 | solute carrier family 16 (monocarboxylate transporter), member 5 | 17q25.1 | 0.293 | 0.483 | 0
|
CASP14 | caspase 14, apoptosis-related cysteine peptidase | 19p13.1 | 0.292 | -0.241 | 5.11e-07
|
LZTS2 | leucine zipper, putative tumor suppressor 2 | 10q24 | 0.292 | 0.409 | 0
|
PPP4C | protein phosphatase 4, catalytic subunit | 16p11.2 | 0.291 | 0.39 | 0
|
RABEP1 | rabaptin, RAB GTPase binding effector protein 1 | 17p13.2 | 0.291 | -0.338 | 1.05e-12
|
CYB561 | cytochrome b561 | 17q23.3 | 0.291 | 0.43 | 0
|
KITLG | KIT ligand | 12q22 | 0.291 | -0.511 | 0
|
ATP6AP1 | ATPase, H+ transporting, lysosomal accessory protein 1 | Xq28 | 0.29 | 0.476 | 0
|
TNNI2 | troponin I type 2 (skeletal, fast) | 11p15.5 | 0.29 | 0.43 | 0
|
SLC9A1 | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | 1p36.1-p35 | 0.289 | 0.432 | 0
|
PLCD3 | phospholipase C, delta 3 | 17q21 | 0.289 | 0.455 | 0
|
ATP6V0C | ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c | 16p13.3 | 0.289 | 0.394 | 0
|
PAPLN | papilin, proteoglycan-like sulfated glycoprotein | 14q24.2 | 0.289 | -0.323 | 9.9e-12
|
TMEM102 | transmembrane protein 102 | 17p13.1 | 0.289 | 0.47 | 0
|
MAFB | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B | 20q12 | 0.288 | -0.38 | 2.73e-16
|
MMRN2 | multimerin 2 | 10q23.31 | 0.288 | 0.44 | 0
|
SUMF1 | sulfatase modifying factor 1 | 3p26.1 | 0.288 | 0.426 | 0
|
CEP19 | centrosomal protein 19kDa | 3q29 | 0.288 | -0.535 | 0
|
SFXN4 | sideroflexin 4 | 10q26.11 | 0.288 | 0.542 | 0
|
ST6GALNAC1 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 17q25.3 | 0.287 | 0.219 | 5.06e-06
|
UGT8 | UDP glycosyltransferase 8 | 4q26 | 0.287 | -0.407 | 0
|
FLJ23867 | | | 0.287 | 0.495 | 0
|
MAL | mal, T-cell differentiation protein | 2q11.1 | 0.286 | 0.481 | 0
|
TMED3 | transmembrane p24 trafficking protein 3 | 15q24-q25 | 0.286 | 0.5 | 0
|
KPNA4 | karyopherin alpha 4 (importin alpha 3) | 3q25.33 | 0.285 | -0.45 | 0
|
ENAH | enabled homolog (Drosophila) | 1q32.2 | 0.285 | -0.433 | 0
|
ZNF219 | zinc finger protein 219 | 14q11 | 0.285 | 0.397 | 0
|
TRIM8 | tripartite motif containing 8 | 10q24.3 | 0.285 | 0.526 | 0
|
KIF9 | kinesin family member 9 | 3p21.31 | 0.285 | 0.442 | 0
|
C17orf51 | chromosome 17 open reading frame 51 | 17p11.2 | 0.285 | -0.434 | 0
|
BID | BH3 interacting domain death agonist | 22q11.2 | 0.284 | 0.446 | 0
|
AP1B1 | adaptor-related protein complex 1, beta 1 subunit | 22q12.2 | 0.284 | 0.515 | 0
|
SNX10 | sorting nexin 10 | 7p15.2 | 0.284 | -0.391 | 0
|
PIGK | phosphatidylinositol glycan anchor biosynthesis, class K | 1p31.1 | 0.284 | -0.468 | 0
|
DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 2q35 | 0.284 | 0.367 | 5.56e-15
|
ANKRD9 | ankyrin repeat domain 9 | 14q32.31 | 0.284 | 0.381 | 1.99e-16
|
CEP128 | centrosomal protein 128kDa | 14q31.1 | 0.283 | -0.508 | 0
|
AGO3 | argonaute RISC catalytic component 3 | 1p34 | 0.283 | -0.433 | 0
|
CAMK2N1 | calcium/calmodulin-dependent protein kinase II inhibitor 1 | 1p36.12 | 0.282 | 0.508 | 0
|
TMEM115 | transmembrane protein 115 | 3p21.31 | 0.282 | 0.419 | 0
|
HIPK2 | homeodomain interacting protein kinase 2 | 7q34 | 0.282 | -0.511 | 0
|
DPY19L2P2 | DPY19L2 pseudogene 2 | 7q22.1 | 0.281 | -0.464 | 0
|
SHISA5 | shisa family member 5 | 3p21.31 | 0.279 | 0.44 | 0
|
VPS37B | vacuolar protein sorting 37 homolog B (S. cerevisiae) | 12q24.31 | 0.279 | 0.481 | 0
|
PLXNB2 | plexin B2 | 22q13.33 | 0.279 | 0.431 | 0
|
VRK2 | vaccinia related kinase 2 | 2p16.1 | 0.278 | -0.461 | 0
|
TFF1 | trefoil factor 1 | 21q22.3 | 0.277 | 0.398 | 0
|
FGFR1OP2 | FGFR1 oncogene partner 2 | 12p12.1 | 0.276 | -0.418 | 0
|
BLZF1 | basic leucine zipper nuclear factor 1 | 1q24 | 0.276 | -0.334 | 1.81e-12
|
S100A4 | S100 calcium binding protein A4 | 1q12-q22 | 0.276 | 0.461 | 0
|
FRAT2 | frequently rearranged in advanced T-cell lymphomas 2 | 10q23-q24.1 | 0.275 | 0.451 | 0
|
DPCD | deleted in primary ciliary dyskinesia homolog (mouse) | 10q24.32 | 0.274 | 0.384 | 6.09e-17
|
UBAC2 | UBA domain containing 2 | 13q32.3 | 0.274 | 0.461 | 0
|
GAK | cyclin G associated kinase | 4p16 | 0.273 | 0.466 | 0
|
YIPF3 | Yip1 domain family, member 3 | 6p21.1 | 0.273 | 0.393 | 0
|
MYBL1 | v-myb avian myeloblastosis viral oncogene homolog-like 1 | 8q22 | 0.273 | -0.407 | 0
|
WWC1 | WW and C2 domain containing 1 | 5q34 | 0.273 | 0.355 | 5.74e-14
|
ZNRF1 | zinc and ring finger 1, E3 ubiquitin protein ligase | 16q22.3 | 0.272 | 0.423 | 0
|
MADD | MAP-kinase activating death domain | 11p11.2 | 0.272 | 0.359 | 2.45e-14
|
HS3ST1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | 4p16 | 0.272 | 0.313 | 4.4e-11
|
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 18q21.32 | 0.272 | -0.356 | 4.28e-14
|
SLC35C2 | solute carrier family 35 (GDP-fucose transporter), member C2 | 20q13.12 | 0.271 | 0.371 | 2.25e-15
|
PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 10p15.1 | 0.271 | -0.393 | 0
|
MCAT | malonyl CoA:ACP acyltransferase (mitochondrial) | 22q13.2 | 0.27 | 0.432 | 0
|
USMG5 | up-regulated during skeletal muscle growth 5 homolog (mouse) | 10q24.33 | 0.27 | 0.443 | 0
|
CNTLN | centlein, centrosomal protein | 9p22.2-p22.1 | 0.268 | -0.484 | 0
|
GALNT3 | polypeptide N-acetylgalactosaminyltransferase 3 | 2q24-q31 | 0.268 | -0.121 | 0.0127
|
ASB3 | ankyrin repeat and SOCS box containing 3 | 2p16.2 | 0.268 | -0.36 | 2.14e-14
|
LINC00482 | long intergenic non-protein coding RNA 482 | 17q25.3 | 0.268 | 0.467 | 0
|
WDPCP | WD repeat containing planar cell polarity effector | 2p15 | 0.268 | -0.388 | 0
|
KIFAP3 | kinesin-associated protein 3 | 1q24.2 | 0.267 | -0.391 | 0
|
LOC100130987 | | | 0.267 | 0.483 | 0
|
GPAT4 | glycerol-3-phosphate acyltransferase 4 | 8p11.21 | 0.266 | 0.327 | 6.06e-12
|
ANXA11 | annexin A11 | 10q22.3 | 0.265 | 0.482 | 0
|
PDCL3P4 | phosducin-like 3 pseudogene 4 | 3q12.3 | 0.265 | 0.256 | 9.22e-08
|
MAFF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F | 22q13.1 | 0.264 | 0.404 | 0
|
DLGAP1-AS1 | DLGAP1 antisense RNA 1 | 18p11.31 | 0.264 | 0.397 | 0
|
TBC1D2 | TBC1 domain family, member 2 | 9q22.32 | 0.264 | -0.049 | 0.316
|
TBCEL | tubulin folding cofactor E-like | 11q23.3 | 0.263 | -0.368 | 4.67e-15
|
AKTIP | AKT interacting protein | 16q12.2 | 0.262 | 0.277 | 6.46e-09
|
RPSAP58 | ribosomal protein SA pseudogene 58 | 19p12 | 0.261 | 0.357 | 3.54e-14
|
FRAT1 | frequently rearranged in advanced T-cell lymphomas 1 | 10q24.1 | 0.261 | 0.424 | 0
|
C5orf42 | chromosome 5 open reading frame 42 | 5p13.2 | 0.261 | -0.46 | 0
|
RPP38 | ribonuclease P/MRP 38kDa subunit | 10p13 | 0.26 | 0.388 | 0
|
CRISPLD1 | cysteine-rich secretory protein LCCL domain containing 1 | 8q21.13 | 0.26 | -0.409 | 0
|
MRPS18A | mitochondrial ribosomal protein S18A | 6p21.3 | 0.26 | 0.374 | 1.14e-15
|
ARSK | arylsulfatase family, member K | 5q15 | 0.258 | -0.466 | 0
|
RPL3 | ribosomal protein L3 | 22q13 | 0.257 | 0.277 | 6.56e-09
|
VWA1 | von Willebrand factor A domain containing 1 | 1p36.33 | 0.257 | 0.368 | 4.04e-15
|
PPAP2C | phospholipid phosphatase 2 | 19p13.3 | 0.256 | 0.394 | 0
|
NANOS1 | nanos homolog 1 (Drosophila) | 10q26.13 | 0.255 | 0.429 | 0
|
KLHL42 | kelch-like family member 42 | 12p11.22 | 0.254 | -0.4 | 0
|
EIF6 | eukaryotic translation initiation factor 6 | 20q11.2 | 0.251 | 0.346 | 2.75e-13
|
BTG3 | BTG family, member 3 | 21q21.1 | 0.251 | -0.258 | 7.12e-08
|
HPS1 | Hermansky-Pudlak syndrome 1 | 10q23.1-q23.3 | 0.251 | 0.401 | 0
|
MAPK13 | mitogen-activated protein kinase 13 | 6p21 | 0.25 | 0.287 | 1.74e-09
|
ADAP1 | ArfGAP with dual PH domains 1 | 7p22.3 | 0.249 | 0.467 | 0
|
DNAJC24 | DnaJ (Hsp40) homolog, subfamily C, member 24 | 11p14.1 | 0.248 | -0.411 | 0
|
OBFC1 | oligonucleotide/oligosaccharide-binding fold containing 1 | 10q25.1 | 0.248 | 0.516 | 0
|
DAP | death-associated protein | 5p15.2 | 0.248 | 0.338 | 9.9e-13
|
SCAMP2 | secretory carrier membrane protein 2 | 15q23-q25 | 0.247 | 0.431 | 0
|
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | 1p31.3 | 0.247 | -0.346 | 2.6e-13
|
ATP11C | ATPase, class VI, type 11C | Xq27.1 | 0.246 | -0.341 | 5.55e-13
|
APEH | acylaminoacyl-peptide hydrolase | 3p21 | 0.246 | 0.387 | 0
|
SEC11A | SEC11 homolog A, signal peptidase complex subunit | 15q25.2 | 0.242 | 0.347 | 2.34e-13
|
SATB2 | SATB homeobox 2 | 2q33.1 | 0.242 | -0.224 | 3.13e-06
|
CLPTM1 | cleft lip and palate associated transmembrane protein 1 | 19q13.3 | 0.24 | 0.398 | 0
|
ACKR2 | atypical chemokine receptor 2 | 3p21.3 | 0.24 | 0.238 | 7.26e-07
|
STK32C | serine/threonine kinase 32C | 10q26.3 | 0.24 | 0.451 | 0
|
RDH13 | retinol dehydrogenase 13 (all-trans/9-cis) | 19q13.42 | 0.24 | 0.41 | 0
|
CEP57L1 | centrosomal protein 57kDa-like 1 | 6q21 | 0.24 | -0.421 | 0
|
C9orf72 | chromosome 9 open reading frame 72 | 9p21.1 | 0.239 | -0.376 | 8.07e-16
|
SNX33 | sorting nexin 33 | 15q23 | 0.238 | 0.277 | 7.15e-09
|
HOXC9 | homeobox C9 | 12q13.13 | 0.237 | -0.022 | 0.654
|
ZDHHC6 | zinc finger, DHHC-type containing 6 | 10q26.11 | 0.237 | 0.458 | 0
|
GPRC5A | G protein-coupled receptor, class C, group 5, member A | 12p13.1 | 0.236 | 0.254 | 1.18e-07
|
LCN2 | lipocalin 2 | 9q34 | 0.231 | 0.09 | 0.0627
|
TMBIM1 | transmembrane BAX inhibitor motif containing 1 | 2q35 | 0.226 | 0.384 | 4.62e-17
|
SH3GL1 | SH3-domain GRB2-like 1 | 19p13.3 | 0.222 | 0.386 | 3.75e-20
|
TPRG1L | tumor protein p63 regulated 1-like | 1p36.32 | 0.222 | 0.271 | 1.54e-08
|
SCAMP4 | secretory carrier membrane protein 4 | 19p13.3 | 0.221 | 0.393 | 0
|
TM9SF3 | transmembrane 9 superfamily member 3 | 10q24.2 | 0.219 | 0.307 | 1.18e-10
|
RIMS2 | regulating synaptic membrane exocytosis 2 | 8q22.3 | 0.219 | -0.289 | 1.34e-09
|
CNNM2 | cyclin and CBS domain divalent metal cation transport mediator 2 | 10q24.32 | 0.213 | 0.378 | 4.25e-16
|
SMAGP | small cell adhesion glycoprotein | 12q13.13 | 0.212 | 0.263 | 3.71e-08
|
SLC27A4 | solute carrier family 27 (fatty acid transporter), member 4 | 9q34.13 | 0.207 | 0.276 | 7.61e-09
|
AMDHD1 | amidohydrolase domain containing 1 | 12q23.1 | 0.194 | -0.301 | 2.49e-10
|